A systematic review of interventions to improve outcomes for young adults with type 1 diabetes
O'Hara, M. C.
Heller, S. R.
Dinneen, S. F.
MetadataShow full item record
This item's downloads: 0 (view details)
Cited 17 times in Scopus (view citations)
O'Hara, M. C. Hynes, L.; O'Donnell, M.; Nery, N.; Byrne, M.; Heller, S. R.; Dinneen, S. F.; , (2016). A systematic review of interventions to improve outcomes for young adults with type 1 diabetes. Diabetic Medicine 34 (6), 753-769
BackgroundMany young adults with Type 1 diabetes experience poor outcomes. The aim of this systematic review was to synthesize the evidence regarding the effectiveness of interventions aimed at improving clinical, behavioural or psychosocial outcomes for young adults with Type 1 diabetes. MethodsElectronic databases were searched. Any intervention studies related to education, support, behaviour change or health service organizational change for young adults aged between 15-30 years with Type 1 diabetes were included. A narrative synthesis of all studies was undertaken due to the large degree of heterogeneity between studies. ResultsEighteen studies (of a possible 1700) were selected and categorized: Health Services Delivery (n = 4), Group Education and Peer Support (n = 6), Digital Platforms (n = 4) and Diabetes Devices (n = 4). Study designs included one randomized controlled trial, three retrospective studies, seven feasibility/acceptability studies and eight studies with a pre/post design. Continuity, support, education and tailoring of interventions to young adults were the most common themes across studies. HbA(1c) was the most frequently measured outcome, but only 5 of 12 studies that measured it showed a significant improvement. ConclusionBased on the heterogeneity among the studies, the effectiveness of interventions on clinical, behavioural and psychosocial outcomes among young adults is inconclusive. This review has highlighted a lack of high-quality, well-designed interventions, aimed at improving health outcomes for young adults with Type 1 diabetes.